RADIOPHARMACEUTICALS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Radiopharmaceuticals in Nuclear Medicine Market - Overview Radiopharmaceuticals in Nuclear Medicine Market by Radioisotope (Technetium-99, Gallium67, Iodine-123, Iodine-125, 18F, Rubidium-82, Yttrium-90, Lutetium-177, Others), By Application (Cardiology, Gastroenterology, Oncology (Brachytherapy, Others), Nephrology, Neurology, Immunology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 Production of radioisotopes takes place through various sources such as nuclear reactor or cyclotrons, which produces radioisotopes and disintegrated products for radiopharmaceutical usage. Some of the ideal properties of radiopharmaceuticals include, pure gamma and beta minus emitter, short effective half-life, and localization only in organ of interest.
The global radiopharmaceuticals market is estimated to account for US$ 8,659.8 Mn in terms of value by the end of 2027. Increasing development in radiotracers is expected to propel growth of the global radiopharmaceuticals market over the forecast period. For instance, in April 2019, researchers from University Hospital Heidelberg reported development of 68Ga-FAPI radiotracer that can identifying nearly 30 types of malignant tumors. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/radiopharmaceuticals-market-70 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Drug regulatory authorities do have legal framework for radiopharmaceuticals. Other inconsistencies include no assessment of safety, efficacy and quality required for radiopharmaceuticals. Therefore, streamlining public safety efforts both from radiation safety and medicine inspections is expected to offer lucrative growth opportunities for market players.
The Oncology segment in the global radiopharmaceuticals market was valued at US$ 3,621.0 Mn in 2019 and is expected to reach US$ 5,630.0 Mn by 2027 at a CAGR of 5.7% during the forecast period. The growth of the segment is attributed to increasing incidence and prevalence of cancer during the forecasted period. The Hospitals segment held dominant position in the global radiopharmaceuticals market in 2019, accounting for 92% share in terms of volume, followed by Diagnostic centers and ambulatory surgical centers, respectively. Increasing healthcare expenditure and infrastructure in developing economies is anticipated to assist the growth of the segments during the forecasted period Major players in the market are focused on gaining regulatory approvals. For instance, in November 2019, Q Biomed Inc. announced the U.S. FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG) to manufacture the company's Strontium-89 Chloride USP, a non-opioid radiopharmaceutical indicated for the treatment of painful skeletal metastases caused by cancer. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/70 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Market Trends Major players in the market are focused on business expansion. For instance, in November 2019, Jubilant Biosys, a subsidiary of Jubilant Lifesciences Limited, a manufacturer of radiopharmaceuticals, announced commencement of two expansion projects in in India at Greater Noida and Bengaluru. Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in November 2019, Bruce Power, Kinectrics & Framatome, and ITM, a biotechnology and radiopharmaceutical group of companies, signed an agreement, in conjunction with Bruce Power’s Life Extension program, to create a framework for isotope production until 2064. Global Radiopharmaceuticals Market: Competitive Landscape Major players operating in the radiopharmaceuticals market include, Siemens Healthineers (Siemens AG), Positron Corporation, Advanced Accelerator Applications, GE Healthcare (General Electric Co.), Mallinckrodt plc., Lantheus Holdings, Inc., Nordion, Inc., Bayer AG, Eckert & Ziegler, and IBA Radiopharma Solutions.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/70 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved